Stay updated with breaking news from Markus Sieger. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Rating) was the target of a significant increase in short interest in the month of May. As of May 31st, there was short interest totalling 61,700 shares, an increase of 11.8% from the May 15th total of 55,200 shares. Based on an average daily volume of 137,900 shares, the […]
Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Rating) was the recipient of a large growth in short interest in the month of May. As of May 31st, there was short interest totalling 61,700 shares, a growth of 11.8% from the May 15th total of 55,200 shares. Based on an average trading volume of 137,900 shares, the […]
Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Rating) Director Markus Sieger acquired 59,881 shares of Cyclo Therapeutics stock in a transaction dated Thursday, April 20th. The stock was purchased at an average cost of $0.71 per share, with a total value of $42,515.51. Following the completion of the purchase, the director now owns 161,051 shares of […]
Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Rating) saw a large decrease in short interest in the month of May. As of May 15th, there was short interest totalling 3,100 shares, a decrease of 49.2% from the April 30th total of 6,100 shares. Based on an average daily trading volume, of 42,600 shares, the days-to-cover ratio […]
Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Rating) was the recipient of a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 64,000 shares, an increase of 257.5% from the March 15th total of 17,900 shares. Based on an average daily trading volume, of 65,800 shares, […]